Article

Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating Agents

2026-07-16

Abstract excerpt

<title>Abstract</title> <p>Human papillomavirus (HPV)-associated malignancies remain a significant global health burden, particularly among individuals with established infection or limited access to prophylactic vaccination. Although the E6 and E7 oncogenes of high-risk HPV types represent attractive therapeutic targets, current vaccine approaches have shown limited clinical efficacy. In this study, we investiga...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1090370f-5b8d-515c-aae9-ed1a93de7043
DOI: 10.21203/rs.3.rs-9890379/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating AgentsDOI 10.21203/rs.3.rs-9890379/v1Read

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)Semantic proximity Read

mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice.Semantic proximity Read

Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.Semantic proximity Read

Enhanced the immunity activity of HPV16 DNA vaccine by the combination CpG oligonucleotides adjuvant cloned into plasmid backbone and IL-28B gene adjuvantSemantic proximity Read

Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteinsSemantic proximity Read

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vectorSemantic proximity Read

Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1Semantic proximity Read

Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope VaccineSemantic proximity Read

Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 proteinSemantic proximity Read

Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.Semantic proximity Read

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated diseaseSemantic proximity Read

DNA vaccines for cervical cancer: from bench to bedsideSemantic proximity Read